Ethicon gets rights to Medscand device:
This article was originally published in Clinica
Ethicon, a Johnson & Johnson subsidiary, has acquired the marketing rights to a female urinary stress incontinence device from Medscand Medical, based in Malmo, Sweden. The device is used to treat urinary stress incontinence by a microinvasive day procedure, called tension-free vaginal tape, which takes 20 minutes and is performed under local anaesthesia. Ethicon expects to launch the device in Europe by the end of the year and in 1998 in the rest of the world.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.